PAVmed Inc.
PAVM
$0.71
$0.034.41%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 39.79M | 24.32M | -57.75M | -61.46M | -64.18M |
Total Depreciation and Amortization | 1.20M | 1.85M | 2.35M | 2.79M | 2.93M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -75.06M | -73.26M | 4.21M | 6.15M | 7.62M |
Change in Net Operating Assets | 512.00K | 1.56M | 3.46M | 3.73M | 1.59M |
Cash from Operations | -33.55M | -45.52M | -47.73M | -48.78M | -52.04M |
Capital Expenditure | -55.00K | -234.00K | -246.00K | -258.00K | -242.00K |
Sale of Property, Plant, and Equipment | -- | 1.00M | 0.00 | 0.00 | 1.00M |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -16.48M | -16.48M | -- | -- | -- |
Other Investing Activities | 350.00K | -650.00K | 0.00 | 0.00 | 0.00 |
Cash from Investing | -16.18M | -16.36M | -246.00K | -258.00K | 758.00K |
Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 10.00M |
Total Debt Repaid | -531.00K | -610.00K | -610.00K | -401.00K | -79.00K |
Issuance of Common Stock | 1.66M | 1.70M | 1.49M | 1.90M | 1.79M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 30.16M | 35.16M | 35.43M | 23.80M | 19.46M |
Cash from Financing | 31.28M | 36.24M | 36.31M | 25.30M | 31.17M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -18.45M | -25.64M | -11.66M | -23.74M | -20.11M |